RIDGEVIEW MEDICAL CENTER
1. Target Overview & Investment Thesis
RIDGEVIEW MEDICAL CENTER is a 109-bed suburban community hospital in CARVER, MN with $287.8M in net patient revenue and a -14.2% operating margin. The hospital serves a payer mix of 25.9% Medicare, 3.2% Medicaid, and 71.0% commercial.
Thesis: Undervalued. Our ML models identify $21.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -14.2% to -6.8% (+736bps).
| Net Revenue HCRIS | $287.8M |
| Current EBITDA COMPUTED | $-40.8M |
| Operating Margin COMPUTED | -14.2% |
| Occupancy HCRIS | 62.6% |
| Revenue / Bed COMPUTED | $2.6M |
| Net-to-Gross HCRIS | 38.2% |
| Distress Probability ML | 43.7% |
2. Market Context & Competitive Position
MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -14.2% places it below the state median. Among 20 size-comparable peers (54-218 beds), the median margin is -6.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (54-218), prioritizing same-state peers. 20 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| RIDGEVIEW MEDICAL CENTER (Target) | MN | 109 | $287.8M | -14.2% |
| SMDC MEDICAL CENTER | MN | 118 | $519.2M | -7.1% |
| MCHS - SOUTHWEST MINNESOTA REG | MN | 118 | $473.6M | -9.8% |
| LAKEVIEW MEMORIAL | MN | 68 | $411.9M | 60.9% |
| HEALTHEAST ST JOHNS HOSPITAL | MN | 184 | $375.8M | -7.7% |
| FAIRVIEW RIDGES HOSPITAL | MN | 172 | $316.2M | 7.0% |
| SANFORD BEMIDJI | MN | 94 | $312.6M | -19.6% |
| ST. JOSEPHS MEDICAL CENTER | MN | 127 | $283.3M | -0.0% |
| MAYO CLNIC HLTH SYS-ALBRT LEA | MN | 79 | $271.9M | -16.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $21.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $6.0M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $5.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $5.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $3.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $184K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-40.8M |
| + RCM Uplift | +$21.2M |
| Pro Forma EBITDA | $-19.6M |
| Current Margin | -14.2% |
| Pro Forma Margin | -6.8% |
| WC Released (1x) | $11.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-62.8M | $-57.3M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-62.8M | $-83.4M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-56.5M | $-33.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-56.5M | $-53.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-69.1M | $-142.8M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-69.1M | $-179.5M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 20 hospitals with 54-218 beds
- Same-state prioritization (n=21)
- Comp margins: P25=-10.0% / P50=-6.3% / P75=3.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.